We bring you the latest news from the healthcare about the health care in the United Kingdom.

maandag 9 april 2018

Blood Cancer Journal - Table of Contents alert Volume 8 March 2018

If you are unable to see the message below, click here to view.
Blood Cancer Journal
TABLE OF CONTENTS

Volume 8 (March 2018)

In this issue
Article
Correspondence
 

Article

 

A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5

Brian S. White, Irena Lanc, Julie O’Neal, Harshath Gupta, Robert S. Fulton et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0062-y

Abstract | Full Text

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group

Eirini Katodritou, Evangelos Terpos, Sossana Delimpasi, Maria Kotsopoulou, Eurydiki Michalis et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0059-6

Abstract | Full Text

Momelotinib therapy for myelofibrosis: a 7-year follow-up

Ayalew Tefferi, Daniela Barraco, Terra L. Lasho, Sahrish Shah, Kebede H. Begna et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0067-6

Abstract | Full Text

Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders

Julie Schanz, Naciye Cevik, Christa Fonatsch, Friederike Braulke, Katayoon Shirneshan et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0061-z

Abstract | Full Text

Correspondence

 

Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

Bei Jia, Liru Wang, David F. Claxton, W Christopher Ehmann, Witold B. Rybka et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0069-4

Abstract | Full Text

miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia

Rosanna H. E. Krakowsky, Alexander A. Wurm, Dennis Gerloff, Christiane Katzerke, Daniela Bräuer-Hartmann et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0070-y

Abstract | Full Text

The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma

Shengjian Huang, Changying Jiang, Hui Zhang, Taylor Bell, Hui Guo et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0066-7

Abstract | Full Text

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

Terra L. Lasho, Rangit Vallapureddy, Christy M. Finke, Abhishek Mangaonkar, Naseema Gangat et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0057-8

Abstract | Full Text

A systematic classification of death causes in multiple myeloma

Elias K. Mai, Eva-Maria Haas, Stephan Lücke, Martin Löpprich, Christina Kunz et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0068-5

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Blood Cancer Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature